We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EIGR market cap is 2.55M. The company's latest EPS is USD -65.4118 and P/E is -0.03.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.02M | 2.7M | 4.12M | 4.64M | 3.29M |
| Operating Income | -26.37M | -24.47M | -22.26M | -19.98M | -16.6M |
| Net Income | -27.11M | -25.14M | -22.78M | -20.7M | -18.03M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 58.63M | 13.48M |
| Operating Income | -51.05M | -68.9M | -62.15M | -30.45M | -92.74M |
| Net Income | -52.39M | -70.25M | -65.05M | -33.92M | -96.78M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 143.74M | 120.14M | 99.23M | 72.36M | 55.65M |
| Total Liabilities | 65.44M | 64.83M | 63.99M | 57.06M | 57.26M |
| Total Equity | 78.31M | 55.31M | 35.24M | 15.3M | -1.6M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 102.45M | 105.14M | 143.59M | 126.4M | 120.14M |
| Total Liabilities | 35.86M | 48.66M | 48.56M | 54M | 64.83M |
| Total Equity | 66.59M | 56.48M | 95.04M | 72.4M | 55.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -60.76M | -83.01M | -24.01M | -46.04M | -60.59M |
| Investing | -12.17M | 9.63M | 13.38M | 43.23M | 62.23M |
| Financing | 77.02M | 76.96M | 41k | 19k | 34k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.67M | -63.61M | -63.19M | -71.34M | -83.01M |
| Investing | -29.09M | -16.47M | -44.79M | 61.53M | 9.63M |
| Financing | 100.98M | 58.2M | 97.46M | 3.17M | 76.96M |
| Market Cap | 2.55M |
| Price to Earnings Ratio | -0.03 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 0.1 |
| Price to Book Ratio | 0.05 |
| Dividend Yield | - |
| Shares Outstanding | 1.48M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 496.02k |
| 52 Week Change | -94.58% |
| 52 Week High | 43.35 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 0.01 (0.58%) |
| Company Name | Eiger BioPharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.eigerbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
